William B. Mitchell

William Beau Mitchell, MD, is Director, Hemostasis and Thrombosis at the Children’s Hospital at Montefiore Einstein and Associate Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Mitchell’s clinical focus centers on pediatric hematology, particularly bleeding and clotting disorders, with a special interest and expertise in platelet disorders.

After earning his Doctor of Medicine at Tufts University School of Medicine in 1994, Dr. Mitchell completed a pediatric internship at Boston Medical Center in 1995, followed by his pediatric residency at the same institution in 1997. He then completed a fellowship in pediatric hematology oncology at Mount Sinai School of Medicine in 2001 and a research fellowship in the laboratory of blood and vascular biology at Rockefeller University in 2006.

Dr. Mitchell’s clinical research interests include novel therapies for rare blood disorders, hematological manifestations of disease, and transition from pediatric to adult care for patients with rare blood disorders. His basic science research interests include mechanisms of action of novel immune thrombocytopenia (ITP) therapies, platelet function in sickle cell disease, and the production of platelets from stem cells. Dr. Mitchell has been principal investigator and site principal investigator on a number of research projects, and he has given several national and international presentations. His work has been published in numerous peer-reviewed publications, books, chapters, and monographs, and he is an Associate Editor for Nature Pediatric Research. He is also a reviewer for many scientific journals, including the Journal of Pediatrics: X, Pediatric Blood and Cancer and the Journal of Thrombosis and Haemostasis.

Dr. Mitchell is board certified by the American Board of Pediatrics in Pediatrics and Pediatric Hematology Oncology. He is a member of the American Society of Hematology (ASH), the International Society for Hemostasis and Thrombosis (ISTH), and the American Society for Pediatric Hematology and Oncology (ASPHO). Dr. Mitchell has received two U.S. patents for his work in “Regulation of Integrin Surface Expression” and “Megakaryocyte and Platelet Production from Stem Cells.”